UROONCRX
Live / Applied — Statement of use — processing complete, to examiner (as of 27 Oct 2026)
What this means for you
Not registered yet, but its 05 Jun 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99219423
- Mark type
- Word mark
- Filed
- 05 Jun 2025
- Published for opposition
- 25 Nov 2025
- Attorney of record
- Andrew S. Ehard
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of radiopharmaceuticals to order or specification of others
- Class 041 — Education and entertainment services: Training services in the use and administration of radiopharmaceuticals
- Class 045 — Legal and security services: Regulatory compliance consultancy services in the medical field
Owner
- Telix Pharmaceuticals Limited, North Melbourne, VIC, AU
- Telix Pharmaceuticals Limited, North Melbourne, VIC, AU
Prosecution history
- 27 Oct 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Oct 2026 — USE AMENDMENT FILED
- 22 Oct 2026 — TEAS STATEMENT OF USE RECEIVED
- 21 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jul 2026 — SOU EXTENSION 1 GRANTED
- 20 Jul 2026 — SOU EXTENSION 1 FILED
- 20 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Jun 2026 — ASSIGNED TO EXAMINER
- 20 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Nov 2025 — PUBLISHED FOR OPPOSITION
- 19 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Oct 2025 — ASSIGNED TO EXAMINER
- 10 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED